Study of duralabhadi vati in management of pittaj mutrakrucchra with special reference to urinary tract infection

RANDOMIZED CONTROL CLINICAL STUDY OF DURALABHADI VATI IN MANAGEMENT OF PITTAJ MUTRAKRUCCHRA WITH SPECIAL REFERENCE TO URINARY TRACT INFECTION

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023416

Enrollment

Registered

2020-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified Health Condition 2: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Duralabhadi vati: 500 mg 2 tab tds for 7 days Control Intervention1: Gokshuradi guggulu vati: 500 mg 2 tab tds for 7 days

Eligibility

Inclusion criteria

Inclusion criteria: Patient with clinical signs and symptoms of pittaj mutrakrucchra described in Ayurvedic text book Age 18 to 60 year both sex patients selected Urine pus cell up to 8/high power field RBCS in urine up to 8/high power field

Exclusion criteria

Exclusion criteria: Diagnosed patient of pregnancy Diagnosed patient of benign prostatic hyperplasia Diagnosed patient of malignancy of any part of urinary tract Phimosis and paraphimosis Traumatic causes. Renal failure Diagnosed urinary tract infection associated with calculus. Diagnosed patient of diabetes mellitus.

Design outcomes

Primary

Measure	Time frame
To study the effect of Duralabhadi vati in the management of pittaj mutrakrucchraTimepoint: 24 weeks	—

Secondary

Measure	Time frame
To study mode of action of duralabhadi vatiTimepoint: 20 weeks	—

Countries

India

Contacts

Public ContactDr Parag Deshmukhe

Hon Shri AnnasahebDange Ayurved Medical College and Post graduation Research Training Center Ashta

pdeshmukhe@yahoo.co.in7719954457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026